Paclitaxel in the Treatment of Carcinosarcoma of the Uterus: A Gynecologic Oncology Group Study

Objective. The goal of this study was to estimate the clinical activity of paclitaxel in patients with persistent or recurrent carcinosarcoma of the uterus who have failed other treatments. Methods. The Gynecologic Oncology Group (GOG) conducted a phase II study of paclitaxel 170 mg/m2 (135 mg/m2 in...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Gynecologic oncology Ročník 83; číslo 2; s. 268 - 270
Hlavní autoři:	Curtin, John P., Blessing, John A., Soper, John T., DeGeest, Koen
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	San Diego, CA Elsevier Inc 01.11.2001 Elsevier
Témata:	Adult Aged Antineoplastic Agents, Phytogenic - adverse effects Antineoplastic Agents, Phytogenic - therapeutic use Biological and medical sciences Carcinosarcoma - drug therapy Drug Administration Schedule Female Female genital diseases Gynecology. Andrology. Obstetrics Humans Infusions, Intravenous Medical sciences Middle Aged Neoplasm Recurrence, Local - drug therapy Paclitaxel - adverse effects Paclitaxel - therapeutic use Tumors Uterine Neoplasms - drug therapy Human Antineoplastic agent Relapse Treatment resistance Treatment efficiency Malignant tumor Female genital diseases Chemotherapy Treatment Uterus Taxane derivatives Paclitaxel Uterine diseases Adult Female Spindle cell carcinoma
ISSN:	0090-8258, 1095-6859
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!